Scotiabank Forecasts Strong Price Appreciation for American Healthcare REIT (NYSE:AHR) Stock

American Healthcare REIT (NYSE:AHR) had its target price raised by research analysts at Scotiabank from $55.00 to $59.00 in a research report issued on Wednesday,Benzinga reports. The brokerage currently has a “sector outperform” rating on the stock. Scotiabank’s price target suggests a potential upside of 11.84% from the stock’s current price.

Several other equities research analysts have also issued reports on AHR. The Goldman Sachs Group set a $60.00 price target on shares of American Healthcare REIT in a report on Monday, March 2nd. BMO Capital Markets initiated coverage on American Healthcare REIT in a research note on Thursday, January 29th. They issued an “outperform” rating and a $55.00 price target for the company. Citigroup reissued a “market outperform” rating on shares of American Healthcare REIT in a report on Monday, March 2nd. UBS Group increased their target price on American Healthcare REIT from $51.00 to $56.00 and gave the company a “buy” rating in a research report on Monday, November 17th. Finally, Royal Bank Of Canada raised their price objective on shares of American Healthcare REIT from $45.00 to $54.00 and gave the company an “outperform” rating in a report on Wednesday, November 12th. One research analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $53.25.

American Healthcare REIT Stock Performance

Shares of AHR stock traded down $0.23 during trading hours on Wednesday, reaching $52.76. 1,375,608 shares of the company’s stock were exchanged, compared to its average volume of 2,894,402. The company has a quick ratio of 0.41, a current ratio of 0.41 and a debt-to-equity ratio of 0.30. American Healthcare REIT has a fifty-two week low of $26.48 and a fifty-two week high of $54.67. The business has a fifty day moving average price of $49.39 and a 200-day moving average price of $46.73. The stock has a market capitalization of $9.33 billion, a P/E ratio of 128.40, a P/E/G ratio of 2.42 and a beta of 0.95.

American Healthcare REIT (NYSE:AHR) last issued its earnings results on Thursday, February 26th. The company reported $0.06 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.46 by ($0.40). American Healthcare REIT had a return on equity of 2.57% and a net margin of 3.09%.The company had revenue of $604.08 million during the quarter, compared to analyst estimates of $617.49 million. During the same period in the previous year, the company posted $0.40 earnings per share. The company’s quarterly revenue was up 11.3% on a year-over-year basis. American Healthcare REIT has set its FY 2026 guidance at 1.990-2.050 EPS. Analysts predict that American Healthcare REIT will post 1.41 EPS for the current fiscal year.

Insider Buying and Selling at American Healthcare REIT

In other news, Director Jeffrey T. Hanson sold 35,570 shares of American Healthcare REIT stock in a transaction that occurred on Monday, December 22nd. The shares were sold at an average price of $48.38, for a total transaction of $1,720,876.60. Following the completion of the transaction, the director directly owned 19,208 shares of the company’s stock, valued at $929,283.04. The trade was a 64.93% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 1.00% of the company’s stock.

Institutional Investors Weigh In On American Healthcare REIT

Institutional investors have recently bought and sold shares of the company. Garton & Associates Financial Advisors LLC purchased a new position in shares of American Healthcare REIT during the 4th quarter worth approximately $26,000. Optiver Holding B.V. raised its holdings in shares of American Healthcare REIT by 83.1% in the 3rd quarter. Optiver Holding B.V. now owns 652 shares of the company’s stock valued at $27,000 after purchasing an additional 296 shares in the last quarter. Trust Co. of Vermont purchased a new stake in shares of American Healthcare REIT during the 3rd quarter worth $28,000. Kemnay Advisory Services Inc. purchased a new position in American Healthcare REIT in the fourth quarter valued at $29,000. Finally, Darwin Wealth Management LLC purchased a new position in shares of American Healthcare REIT in the 2nd quarter valued at about $31,000. 16.68% of the stock is currently owned by institutional investors and hedge funds.

About American Healthcare REIT

American Healthcare REIT, Inc (NYSE: AHR) was a publicly traded real estate investment trust focused on acquiring, owning and managing healthcare‐related properties across the United States. The company’s portfolio spanned senior housing communities, skilled nursing facilities, medical office buildings and outpatient care centers, all operated under long‐term net lease or triple‐net lease structures designed to provide stable, predictable rental income.

Employing a strategy of partnering with established healthcare operators, American Healthcare REIT targeted properties in both major metropolitan areas and high‐growth secondary markets to capitalize on demographic trends such as an aging population and increased demand for outpatient services.